Login / Signup
African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies.
Mark A Fiala
Published in:
Cancer (2019)
Keyphrases
</>
african american
monoclonal antibody
end stage renal disease
ejection fraction
patient reported outcomes
combination therapy
patient reported